Evaluation of efficacy of budesonide inhalation suspension for infants with severe intermittent asthma - A multicenter, open, randomized, parallel-group study
- Conditions
- bronchial asthma
- Registration Number
- JPRN-UMIN000001557
- Lead Sponsor
- Mie National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1)Infants of less than 2500 grams in weight at the birth 2)Infants who have chronic ailment in lungs, heart, kidney, liver, and blood, etc. 3)Infants to whom long-term control asthma medicine were administered (however, the case who were administered anti-leukotriene medicines within one week three months ago is not excluded) 4)Infants who have previous history of adrenal cortical insufficiency or accentuation syndrome 5)Infants who have received systemic steroid in the past (however, the case who were administered it for the diseases other than asthma (croup syndrome etc.) before three months or more is not excluded) 6)Infants who were taking steroid medicines continuously within six months in the past (including point bribes, not including medicines for external application) 7)Infants who required two weeks or more for the acute treatment 8)Infants who have previous history of hypersensitivity for treatment 9)Infants of hospitalization by bacterial pneumonia or RSV minute bronchitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method